A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from ...

The Bajau tribe off the coast of Indonesia was the first known humans to develop a genetic mutation that helped them adapt to ...

SELLAS Life Sciences Group, Inc. has announced promising preclinical results for SLS009, a selective CDK9 inhibitor, in treating TP53 mutated Acute Myeloid Leukemia (AML) cells, which typically ...